The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.
Open accessAbstract
Simian sarcoma virus, an acutely transforming primate retrovirus with capacity to induce gliomas and sarcomas in experimental animals, has acquired its transforming properties by transducing the cellular gene sequences that encode one of the constituent chains of platelet-derived growth factor. Suramin, a drug used in the treatment of trypanosomiasis and onchocerciasis, has previously been reported to inhibit the interaction of platelet-derived growth factor with its cell surface receptor. We show here that suramin efficiently reverts the simian sarcoma virus-induced transformed phenotype in human and rat fibroblasts and propose that this is due to neutralization of an externalized v-sis product. Moreover, we show that suramin inhibits the action of a broad spectrum of growth factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Waterfield, M. D., Scrace, G. T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, Å., Westermark, B., Heldin, C.-H., Huang, J. S., & Deuel, T. F. (1983) · Nature · doi:10.1038/304035a0 · Cited by 1,616
Self-citationDoolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., & Antoniades, H. N. (1983) · Science · doi:10.1126/science.6304883 · Cited by 1,536
Heldin, C. H., Westermark, B., & Wasteson, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3664 · Cited by 420
Self-citationSuramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III
Mitsuya, H., Popovic, M., Yarchoan, R., Matsushita, S., Gallo, R. C., & Broder, S. (1984) · Science · doi:10.1126/science.6091268 · Cited by 397
Robbins, K. C., Antoniades, H. N., Devare, S. G., Hunkapiller, M. W., & Aaronson, S. A. (1983) · Nature · doi:10.1038/305605a0 · Cited by 342
C-Type Virus in Tumor Tissue of a Woolly Monkey (Lagothrix spp.) With Fibrosarcoma 2
(1971) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/47.4.881 · Cited by 295
Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses
De Clercq, E. (1979) · Cancer Letters · doi:10.1016/0304-3835(79)90017-x · Cited by 288
Suramin: With Special Reference to Onchocerciasis
Hawking, F. (1978) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60486-x · Cited by 284
McKeehan, W. L., McKeehan, K. A., Hammond, S. L., & Ham, R. G. (1977) · In Vitro · doi:10.1007/bf02615100 · Cited by 271
Huang, J. S., Huang, S. S., & Deuel, T. F. (1984) · Cell · doi:10.1016/0092-8674(84)90193-4 · Cited by 259
Cited by
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
PLATELET-DERIVED GROWTH FACTOR
Ross, R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92760-8 · Cited by 940
Kumar, R. K. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1234 · Cited by 559
Platelet-derived growth factor: mechanism of action and possible in vivo function.
Heldin, C. H., & Westermark, B. (1990) · Cell Regulation · doi:10.1091/mbc.1.8.555 · Cited by 486
Self-citationKelley, J. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.3.765 · Cited by 462
Involvement of growth factor receptors in the mammalian UVC response
Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., & Rahmsdorf, H. J. (1994) · Cell · doi:10.1016/0092-8674(94)90272-0 · Cited by 444
Expression cDNA Cloning of the KGF Receptor by Creation of a Transforming Autocrine Loop
Miki, T., Fleming, T. P., Bottaro, D. P., Rubin, J. S., Ron, D., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846048 · Cited by 420
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells
Coffey, R. J., Leof, E. B., Shipley, G. D., & Moses, H. L. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041320120 · Cited by 379
Suramin: an anticancer drug with a unique mechanism of action.
Stein, C. A., LaRocca, R. V., Thomas, R., McAtee, N., & Myers, C. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.499 · Cited by 375
Structural and functional studies on platelet-derived growth factor.
Heldin, C. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05523.x · Cited by 337
Self-citationLiang, Y.-C., Lin-shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971001)67:1<55::aid-jcb6>3.0.co;2-v · Cited by 294
Assanah, M., Lochhead, R., Ogden, A., Bruce, J., Goldman, J., & Canoll, P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0514-06.2006 · Cited by 292
UV activates growth factor receptors via reactive oxygen intermediates.
Huang, R. P., Wu, J. X., Fan, Y., & Adamson, E. D. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.1.211 · Cited by 276
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Regenass, U., & Lydon, N. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2558 · Cited by 270
RetractedAutocrine Stimulation of Intracellular PDGF Receptors in v- sis -Transformed Cells
Keating, M. T., & Williams, L. T. (1988) · Science · doi:10.1126/science.2829358 · Cited by 261
Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
Cao, Y. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.002 · Cited by 190
Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation
LaRocca, R. V., Cooper, M. R., Uhrich, M., Danesi, R., Walther, M. M., Linehan, W. M., & Myers, C. E. (1991) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01399-9 · Cited by 57
Suramin in adrenocortical cancer: limited efficacy and serious toxicity
Arlt, W., Reincke, M., Siekmann, L., WInkelmann, W., & Allolio, B. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02549.x · Cited by 36
“, 1984; Hosang, 1985), epidermal growth factor (EGF) (Betsholtz et al., 1986), transforming growth factor beta (TGF-P) (Coffey et al.”
Background
Metadata
- Authors
- Betsholtz, C., Johnsson, A., Heldin, C. H., & Westermark, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1986-09
- Volume
- 83
- Issue
- 17
- Pages
- 6440-6444
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2028561494
- Cited by
- 264
- References
- 24
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.